PLGAミクロスフィアの薬物放出挙動予測における機械学習
Andrew F Catapano1, Ling Zheng1, Xudong Yuan2
1Monmouth University, West Long Branch, NJ, USA.
AMIA ... Annual Symposium proceedings. AMIA Symposium
|February 23, 2026
まとめ
機械学習はポリ(乳酸-共-グリコール酸)(PLGA)ミクロスフィアからの薬物放出を正確に予測します。このアプローチは、非効率的な試行錯誤の開発を削減し、長時間作用型薬物製剤を最適化します。
科学分野:
- 生体材料科学
- 製剤技術
- 計算化学
背景:
- ポリ(乳酸-共-グリコール酸)(PLGA)ミクロスフィアは、持続的な薬物送達に不可欠であり、患者のコンプライアンスを向上させます。
- 現在の開発は、薬物放出に影響を与える複雑な製剤要因により、非効率的な試行錯誤の方法に依存しています。
研究 の 目的:
- PLGAミクロスフィアからのインビトロ薬物放出プロファイルを予測するための機械学習モデルを開発および検証すること。
- 薬物放出速度論に影響を与える主要な製剤パラメータを特定すること。
主な方法:
- 科学文献から113のPLGA製剤の包括的なデータセットを編集しました。
- 予測性能のために複数の機械学習アルゴリズムをトレーニングおよび評価しました。
- 放出に影響を与える重要な要因を理解するために特徴量重要度分析を実施しました。
主要な成果:
- 最適な機械学習モデルは、R² = 0.9415、RMSE = 6.99%、MAE = 4.35%で高い精度を達成しました。
- モデルは、PLGAミクロスフィアからのインビトロ薬物放出に対して堅牢な予測能力を示しました。
- 特徴量重要度分析により、薬物放出に影響を与える主要因が特定されました。
結論:
- 機械学習は、PLGAベースの薬物送達システムの合理的な設計と最適化のための強力なツールを提供します。
- 薬物放出プロファイルの正確な予測は、製剤開発を加速し、治療結果を改善することができます。
- このデータ駆動型アプローチは、長時間作用型注射剤の開発を効率化します。
関連する概念動画
Modified-Release Drug Delivery Systems: Rate-Programmed II
44
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
44
Modified-Release Drug Delivery Systems: Stimuli-Activated
35
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
35
Modified-Release Drug Delivery Systems: Rate-Programmed I
35
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
35
Modified-Release Drug Delivery Systems: Classification
47
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
47
Modified-Release Drug Delivery Systems: Drug Release Characteristics
53
Drug release from modified-release dosage forms is designed to achieve specific therapeutic effects by controlling the rate and extent of drug release. The classification of these drug release systems is based on key pharmacokinetic assumptions: drug disposition follows first-order kinetics, drug release is the rate-limiting step in absorption, and the released drug is rapidly and completely absorbed.There are four major models of drug release patterns. The first model is the slow zero-order...
53
Modified-Release Drug Delivery Systems: Influencing Factors
47
Modified-release drug delivery systems are designed to optimize the therapeutic effect of drugs by minimizing side effects, reducing the dosage required, and controlling drug release to align with pharmacokinetic and pharmacodynamic needs. The system depends on two key factors: the drug's release from the formulation and its movement through the body to the target site. Unlike conventional dosage forms, where absorption is the limiting step, the rate of drug release is the key determinant in...
47


